Guggenheim Capital’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-81,971
| Closed | -$8M | – | 3160 |
|
|
2015
Q1 | $8M | Buy |
81,971
+18,123
| +28% | +$1.77M | 0.02% | 947 |
|
|
2014
Q4 | $5.92M | Sell |
63,848
-1,700
| -3% | -$158K | 0.01% | 1045 |
|
|
2014
Q3 | $4.51M | Buy |
65,548
+12,206
| +23% | +$839K | 0.01% | 1234 |
|
|
2014
Q2 | $5.59M | Sell |
53,342
-7,331
| -12% | -$768K | 0.01% | 1106 |
|
|
2014
Q1 | $5.03M | Sell |
60,673
-1,934
| -3% | -$160K | 0.01% | 1115 |
|
|
2013
Q4 | $4.05M | Buy |
+62,607
| New | +$4.05M | 0.01% | 1209 |
|